Amphastar Financials
AMPH Stock | USD 44.55 0.46 1.04% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.97 | 0.9282 |
|
| |||||
Current Ratio | 2.26 | 2.1721 |
|
|
Investors should never underestimate Amphastar's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Amphastar's cash flow, debt, and profitability to make informed and accurate decisions about investing in Amphastar P.
Net Income |
|
Amphastar | Select Account or Indicator |
Understanding current and past Amphastar Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amphastar's financial statements are interrelated, with each one affecting the others. For example, an increase in Amphastar's assets may result in an increase in income on the income statement.
Amphastar Earnings Geography
Amphastar Stock Summary
Amphastar competes with Collegium Pharmaceutical, Alkermes Plc, Evolus, Neurocrine Biosciences, and Ironwood Pharmaceuticals. Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Amphastar Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1761 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US03209R1032 |
CUSIP | 03209R103 |
Location | California; U.S.A |
Business Address | 11570 6th Street, |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.amphastar.com |
Phone | 909 980 9484 |
Currency | USD - US Dollar |
Amphastar Key Financial Ratios
Return On Equity | 0.24 | ||||
Profit Margin | 0.22 % | ||||
Operating Margin | 0.30 % | ||||
Price To Sales | 2.93 X | ||||
Revenue | 644.39 M |
Amphastar Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 587.0M | 631.2M | 671.5M | 742.0M | 1.5B | 1.6B | |
Other Current Liab | 2.0M | 67.8M | 64.3M | 60.7M | 190.1M | 199.6M | |
Other Liab | 13.7M | 18.7M | 22.7M | 21.9M | 25.2M | 26.5M | |
Net Debt | (7.1M) | (25.4M) | (21.7M) | (53.5M) | 479.3M | 503.3M | |
Retained Earnings | 116.4M | 117.8M | 180.3M | 271.7M | 409.3M | 429.7M | |
Accounts Payable | 77.1M | 24.4M | 22.2M | 20.5M | 25.4M | 32.3M | |
Cash | 73.7M | 92.6M | 126.4M | 156.1M | 144.3M | 96.7M | |
Other Assets | 37.0M | 50.9M | 39.1M | 59.4M | 68.3M | 35.9M | |
Long Term Debt | 39.4M | 34.2M | 74.8M | 72.8M | 589.6M | 619.1M | |
Net Receivables | 45.7M | 66.0M | 78.8M | 88.8M | 114.9M | 58.4M | |
Good Will | 3.6M | 3.9M | 3.3M | 3.1M | 3.2M | 3.5M | |
Inventory | 110.5M | 96.8M | 92.8M | 103.6M | 105.8M | 91.3M | |
Other Current Assets | 9.5M | 11.2M | 9.8M | 17.7M | 21.1M | 22.1M | |
Total Liab | 159.4M | 182.5M | 226.0M | 213.3M | 873.5M | 917.2M | |
Total Current Assets | 255.2M | 279.7M | 318.1M | 378.3M | 489.6M | 277.4M | |
Short Term Debt | 10.9M | 19.0M | 8.2M | 9.1M | 8.2M | 9.9M | |
Intangible Assets | 37.5M | 36.7M | 35.6M | 34.2M | 610.1M | 640.6M | |
Net Tangible Assets | 340.2M | 361.7M | 406.7M | 491.4M | 565.1M | 361.3M | |
Long Term Debt Total | 39.4M | 34.2M | 74.8M | 72.8M | 83.8M | 48.0M | |
Capital Surpluse | 367.3M | 410.1M | 422.4M | 455.1M | 523.3M | 374.6M |
Amphastar Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 119K | 374K | 885K | 1.8M | 27.2M | 28.5M | |
Total Revenue | 322.4M | 349.8M | 437.8M | 499.0M | 644.4M | 343.3M | |
Gross Profit | 131.9M | 143.3M | 199.7M | 248.9M | 344.0M | 361.2M | |
Operating Income | (39K) | (14.2M) | 43.1M | 78.8M | 197.0M | 206.8M | |
Ebit | (39K) | 5.0M | 85.0M | 78.8M | 199.7M | 209.7M | |
Research Development | 68.9M | 67.2M | 60.9M | 74.8M | 73.7M | 54.9M | |
Ebitda | 21.1M | 30.2M | 111.8M | 107.5M | 241.5M | 253.5M | |
Cost Of Revenue | 190.4M | 206.5M | 238.0M | 250.1M | 300.4M | 199.2M | |
Income Before Tax | 60.2M | 4.6M | 84.1M | 116.0M | 171.4M | 179.9M | |
Net Income | 48.9M | 1.1M | 62.1M | 91.4M | 137.5M | 144.4M | |
Income Tax Expense | 13.7M | 3.5M | 20.6M | 23.5M | 31.8M | 33.4M | |
Tax Provision | 13.7M | 3.5M | 20.6M | 23.5M | 34.5M | 36.2M | |
Interest Income | 997K | 642K | 601K | 1.3M | 3.7M | 3.9M | |
Net Interest Income | 878K | 268K | (284K) | (525K) | (14.5M) | (13.8M) |
Amphastar Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (41.1M) | 15.3M | 1.3M | (11.7M) | (1.7M) | (1.8M) | |
Change In Cash | (12.7M) | 19.0M | 32.1M | 29.7M | (11.8M) | (11.2M) | |
Free Cash Flow | 207K | 23.4M | 70.5M | 65.1M | 145.3M | 152.6M | |
Depreciation | 21.1M | 25.2M | 26.8M | 28.7M | 41.8M | 21.5M | |
Other Non Cash Items | 1.0M | 240K | (13.0M) | (878K) | 20.7M | 21.8M | |
Capital Expenditures | 41.6M | 33.9M | 27.5M | 24.0M | 38.2M | 30.4M | |
Net Income | 46.5M | 1.1M | 63.3M | 91.4M | 137.5M | 144.4M | |
End Period Cash Flow | 75.6M | 94.5M | 126.6M | 156.3M | 144.5M | 94.4M | |
Investments | (8.8M) | (1.1M) | 1.4M | (7.8M) | (546.3M) | (519.0M) | |
Change Receivables | 6.7M | (20.2M) | (14.9M) | (10.1M) | (9.1M) | (9.6M) | |
Net Borrowings | (3.2M) | (880K) | 30.4M | (2.2M) | (2.0M) | (1.9M) | |
Change To Netincome | 22.9M | 20.6M | 8.0M | 2.7M | 3.1M | 3.0M |
Amphastar Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amphastar's current stock value. Our valuation model uses many indicators to compare Amphastar value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amphastar competition to find correlations between indicators driving Amphastar's intrinsic value. More Info.Amphastar P is rated third in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about 0.36 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Amphastar P is roughly 2.75 . As of now, Amphastar's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amphastar's earnings, one of the primary drivers of an investment's value.Amphastar's Earnings Breakdown by Geography
Amphastar P Systematic Risk
Amphastar's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amphastar volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Amphastar P correlated with the market. If Beta is less than 0 Amphastar generally moves in the opposite direction as compared to the market. If Amphastar Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amphastar P is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amphastar is generally in the same direction as the market. If Beta > 1 Amphastar moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Amphastar Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Amphastar's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Amphastar growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Amphastar November 21, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Amphastar help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amphastar P. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amphastar P based on widely used predictive technical indicators. In general, we focus on analyzing Amphastar Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amphastar's daily price indicators and compare them against related drivers.
Information Ratio | (0.05) | |||
Maximum Drawdown | 17.3 | |||
Value At Risk | (3.61) | |||
Potential Upside | 3.37 |
Complementary Tools for Amphastar Stock analysis
When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |